PAIGE GOULETTE: Open Payments
NPI 1164120556 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,582 in 90 payments from 14 companies in 2025. Trend: 2023 $1,914 · 2024 $5,580 · 2025 $10,582
Consulting: $5,036Speaker / faculty: $2,138Travel & lodging: $1,827Food & beverage: $1,582
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 7 | $4,812 |
| TG Therapeutics, Inc. | 14 | $3,243 |
| GENZYME CORPORATION | 4 | $1,497 |
| ABBVIE INC. | 25 | $243 |
| Biogen, Inc. | 4 | $242 |
| EMD Serono, Inc. | 22 | $171 |
| Genentech, Inc. | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| PFIZER INC. | 3 | $54 |
| Celgene Corporation | 2 | $31 |
Products named: Ocrevus, BRIUMVI, TYSABRI, QULIPTA, Enspryng, KESIMPTA, BOTOX, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across MI — which companies pay providers there.
